Monash Business School joins project to cut medicine overuse, hospital stays

1 July 2021

Dr Laura Fanning and Associate Professor Dennis Petrie

Researchers from Monash Business School’s Centre for Health Economics (CHE) will work to decrease the number of medication-related problems and hospital admissions in Australia, as part of a $2.5 million multi-university project supported by the Medical Research Future Fund.

Associate Professor Dennis Petrie and Dr Laura Fanning are collaborating on the project co-led by Dr Jean Spinks (Griffith University), a former CHE staff member and PhD student, and Professor Lisa Nissen (QUT).

Serious medication-related problems can lead to a range of life-threatening issues such as haemorrhage, exacerbation of heart failure, renal failure or acute asthma, causing unplanned hospital stays, costly health complications, and even death.

The three-year collaborative trial will use health record data to automate the detection of medication safety issues before harm occurs.

Other important aspects of the trial will include co-design of an intervention in consultation with consumers and health practitioners, evaluation and refinement of incentive payments for health workforce engagement.

It has a particular focus on Aboriginal and Torres Strait Islander people, who use a lot of medication for chronic disease and may have reduced access to healthcare.

Pharmacists, working collaboratively with GPs, Primary Health Networks and Aboriginal Community Controlled Health Organisations (ACCHOs), will also systematically address issues such as under-prescribing, over-prescribing or incomplete therapeutic monitoring.

The study also includes partners from the Department of General Practice, the National Aboriginal Community Controlled Health Organisation (NACCHO), MedAdvisor, the Pharmaceutical Society of Australia, the Pharmacy Guild of Australia and more.